EDW Pharma - Specialty Pharmaceutical Company Investing in Better Medicine

About EDW Pharma

Providing valuable therapeutics options and support programs that make a positive difference in the lives of patients and healthcare providers.

A specialty pharmaceutical company committed to investing in and commercializing impactful medicines in therapeutic areas with unfulfilled needs.

EDW’s main emphasis is on sales and marketing of neurology, womens health, and urology products.

TIGLUTIK® – a different riluzole therapy for ALS. It is the only formulation of riluzole indicated for both oral and PEG tube administration.

Urogesic Blue™ – a urinary antiseptic/antispasmodic for the treatment of discomfort from lower urinary tract infections.

A portfolio of products comprised of prenatal vitamins, an iron supplement, and a therapeutic vaginal gel.

ProCort® – a prescription hemorrhoid treatment containing Invisicare®, a patented system which holds active ingredients on the skin longer.

A portfolio of products comprised of antihistamines, nasal decongestants, and cough expectorants.

TIGLUTIK® – a different riluzole therapy for ALS. It is the only formulation of riluzole indicated for both oral and PEG tube administration.

Urogesic Blue™ – a urinary antiseptic/antispasmodic for the treatment of discomfort from lower urinary tract infections.

A portfolio of products comprised of prenatal vitamins, an iron supplement, and a therapeutic vaginal gel.

ProCort® – a prescription hemorrhoid treatment containing Invisicare®, a patented system which holds active ingredients on the skin longer.

A portfolio of products comprised of antihistamines, nasal decongestants, and cough expectorants.